If size were directly correlated with stock market performance, CVS Health (NYSE: CVS) and Johnson Johnson (NYSE: JNJ) would always perform well as they are among the largest healthcare stocks in the U.S. However, both corporations have faced company-specific issues that have held them back, and as of this writing, they aren't that far off from their 52-week lows.

Despite their struggles, CVS Health and Johnson Johnson have some major redeeming qualities, especially for income-seeking and long-term investors. Let's find out why these healthcare stocks are still worth buying and holding forever.

CVS Health is one of the most prominent and recognizable pharmacy chains in the U.S. However, the company has faced some issues this year, especially as it continues to disappoint investors by revising its guidance downward. In the third quarter, CVS announced that it now expects earnings per share (EPS) for its fiscal 2023 to come in between $6.37 and $6.61, down from its previous projection of the range of $6.53 to $6.75.

Continue reading

Source Fool.com